îæ€çŽ¢
îæ€çŽ¢
î
Elevance Health Inc
ELVîãŠã©ãããªã¹ãã«è¿œå
396.210USD
-6.060-1.51%
çµå€Â 05/20, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
86.12Bæ䟡ç·é¡
16.75çŽè¿12ã¶æPER
î
詳现æ å ± Elevance Health Inc äŒæ¥å
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Elevance Health Incã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãELV
äŒç€ŸåElevance Health Inc
äžå Žæ¥Oct 30, 2001
æé«çµå¶è²¬ä»»è
ãCEOãBoudreaux (Gail K)
åŸæ¥å¡æ°103158
蚌åžçš®é¡Ordinary Share
決ç®ææ«Oct 30
æ¬ç€Ÿæåšå°220 Virginia Avenue
éœåžINDIANAPOLIS
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·46204
é»è©±çªå·18003311476
ãŠã§ããµã€ãhttps://www.elevancehealth.com/
äŒæ¥ã³ãŒãELV
äžå Žæ¥Oct 30, 2001
æé«çµå¶è²¬ä»»è
ãCEOãBoudreaux (Gail K)
Elevance Health Incã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.91K
+5.68%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
5.49K
+10.26%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
5.35K
+10.52%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
3.92K
+56.79%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
2.21K
+25.49%
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mr. Lewis (Lew) Hay, III
Mr. Lewis (Lew) Hay, III
Independent Director
Independent Director
--
--
Mr. Peter D. (Pete) Haytaian
Mr. Peter D. (Pete) Haytaian
Executive Vice President and President, Carelon and CarelonRx
Executive Vice President and President, Carelon and CarelonRx
--
--
Mr. R. Kerry Clark
Mr. R. Kerry Clark
Independent Director
Independent Director
--
--
Ms. Gail K. Boudreaux
Ms. Gail K. Boudreaux
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.91K
+5.68%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
5.49K
+10.26%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
5.35K
+10.52%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
3.92K
+56.79%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
2.21K
+25.49%
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
åçå èš³
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
äºæ¥å¥USD
äŒç€Ÿå
åç
æ¯ç
Premiums
164.64B
0.00%
Product revenue
24.47B
0.00%
Service fees
8.47B
0.00%
Reconciliation
1.54B
0.00%
Operating revenue - affliated
0.00
0.00%
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äºæ¥å¥USD
äŒç€Ÿå
åç
æ¯ç
Premiums
164.64B
0.00%
Product revenue
24.47B
0.00%
Service fees
8.47B
0.00%
Reconciliation
1.54B
0.00%
Operating revenue - affliated
0.00
0.00%
æ ªäž»
æŽæ°æå»: Sun, May 10
æŽæ°æå»: Sun, May 10
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Vanguard Capital Management, LLC
6.61%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Investment Management (US)
4.76%
Wellington Management Company, LLP
3.82%
T. Rowe Price Associates, Inc.
3.28%
ä»ã®
76.12%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Vanguard Capital Management, LLC
6.61%
BlackRock Institutional Trust Company, N.A.
5.41%
State Street Investment Management (US)
4.76%
Wellington Management Company, LLP
3.82%
T. Rowe Price Associates, Inc.
3.28%
ä»ã®
76.12%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Investment Advisor
50.16%
Investment Advisor/Hedge Fund
33.29%
Hedge Fund
2.81%
Pension Fund
2.50%
Research Firm
2.21%
Bank and Trust
1.96%
Sovereign Wealth Fund
1.45%
Family Office
0.27%
Family Office
0.27%
ä»ã®
5.07%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
3164
206.68M
95.17%
-8.94M
2025Q4
3063
205.92M
97.95%
+22.74K
2025Q3
3138
205.95M
97.05%
-3.45M
2025Q2
3116
209.73M
96.68%
-566.57K
2025Q1
3115
208.90M
96.86%
-10.38M
2024Q4
3105
212.00M
93.76%
+298.05K
2024Q3
2993
212.22M
94.67%
-2.15M
2024Q2
2959
214.26M
94.25%
+1.04M
2024Q1
2925
213.00M
94.22%
-6.19M
2023Q4
2869
213.96M
93.90%
-1.80M
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
BlackRock Institutional Trust Company, N.A.
11.76M
5.35%
-46.57K
-0.39%
Dec 31, 2025
State Street Investment Management (US)
10.34M
4.71%
-4.70K
-0.05%
Dec 31, 2025
Wellington Management Company, LLP
8.29M
3.77%
+1.67M
+25.20%
Dec 31, 2025
T. Rowe Price Associates, Inc.
7.12M
3.24%
+1.61M
+29.33%
Dec 31, 2025
Sanders Capital, LLC
5.75M
2.62%
-18.05K
-0.31%
Dec 31, 2025
Artisan Partners Limited Partnership
5.03M
2.29%
+455.95K
+9.96%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.12M
2.33%
-19.30K
-0.38%
Dec 31, 2025
Harris Associates L.P.
4.79M
2.18%
+1.60M
+50.31%
Dec 31, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
iShares U.S. Healthcare Providers ETF
4.43%
Monarch Dividend Plus Index ETF
3.25%
John Hancock Fundamental All Cap Core ETF
2.45%
GMO US Quality ETF
2.35%
VictoryShares Free Cash Flow ETF
2.32%
Bushido Capital US Equity ETF
2.2%
State Street SPDR S&P Health Care Services ETF
2.11%
First Eagle Global Equity ETF
2.03%
First Trust Total US Market AlphaDEX ETF
1.75%
First Trust Health Care Alphadex Fund
1.71%
詳现ãèŠã
iShares U.S. Healthcare Providers ETF
æ¯ç4.43%
Monarch Dividend Plus Index ETF
æ¯ç3.25%
John Hancock Fundamental All Cap Core ETF
æ¯ç2.45%
GMO US Quality ETF
æ¯ç2.35%
VictoryShares Free Cash Flow ETF
æ¯ç2.32%
Bushido Capital US Equity ETF
æ¯ç2.2%
State Street SPDR S&P Health Care Services ETF
æ¯ç2.11%
First Eagle Global Equity ETF
æ¯ç2.03%
First Trust Total US Market AlphaDEX ETF
æ¯ç1.75%
First Trust Health Care Alphadex Fund
æ¯ç1.71%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
5.24B
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
Apr 21, 2026
ELV.NB Interim Cash Dividend of gross USD 1.72 paid on Jun 25, 2026 going ex on Jun 10, 2026
Jun 10, 2026
Jun 25, 2026
Jun 10, 2026
Jan 28, 2026
ELV.NB Interim Cash Dividend of gross USD 1.72 paid on Mar 25, 2026 going ex on Mar 10, 2026
Mar 10, 2026
Mar 25, 2026
Mar 10, 2026
Oct 15, 2025
ELV.NB Final Cash Dividend of gross USD 1.71 paid on Dec 19, 2025 going ex on Dec 05, 2025
Dec 05, 2025
Dec 19, 2025
Dec 05, 2025
Jul 17, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Sep 25, 2025 going ex on Sep 10, 2025
Sep 10, 2025
Sep 25, 2025
Sep 10, 2025
Apr 22, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Jun 25, 2025 going ex on Jun 10, 2025
Jun 10, 2025
Jun 25, 2025
Jun 10, 2025
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
詳现ãèŠã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
